A Randomized, Double-Blind, Placebo-Controlled Study Comparing Aflibercept Versus Placebo on the QTc Interval in Cancer Patients Treated With Docetaxel.
Phase of Trial: Phase I
Latest Information Update: 04 Nov 2014
At a glance
- Drugs Aflibercept (Primary) ; Docetaxel
- Indications Solid tumours
- Focus Adverse reactions
- Acronyms QUTIE
- Sponsors Sanofi
- 13 Dec 2011 Actual end date changed from 1 Sep 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
- 13 Dec 2011 Actual patient no 88 added as reported by ClinicalTrials.gov.
- 23 Sep 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.